Articles related to CHEMOTHERAPY

Recent research from Brown University suggests that the SARS-CoV-2 spike protein could interfere with cancer treatment efficacy by affecting the p53 gene’s ability to suppress tumor growth and repair DNA.

Explore new horizons in advanced hepatocellular carcinoma treatment with emerging data on lenvatinib and cisplatin’s potential efficacy as a second-line therapy and the promising triple combination therapy showing significant response rates.

Explore key points for patient communication on chemotherapy, offering a clear framework to discuss treatment goals, processes, and side effects, enhancing patient understanding and engagement in their care journey.

In a recent phase 3 trial, a low-dose chemotherapy regimen demonstrated noninferior efficacy to standard-dose regimens in pediatric AML patients, while significantly reducing non-hematologic toxicities, an important consideration in pediatric oncology.

In a recent study, researchers found that, although pembrolizumab increased the pathological complete response in gastric cancer patients, it did not significantly improve event-free survival.

The GCIG INTERLACE study has demonstrated a significant improvement in 5-year survival rates in advanced cervical cancer, from 72% to 80%, with the addition of induction chemotherapy to standard-of-care chemoradiation.